Real-World Study on the Impact of Atopic Dermatitis From a Caregiver Perspective

PeriPharm

Status: Not yet enrolling

Conditions: Atopic Dermatitis; Eczema Atopic Dermatitis; Burden; Caregiver; Eczema

Treatments: Other: No Intervention: Observational Cohort

Study type: Observational

Funder types: Other

Identifiers

NCT07323394

PROxy96AD

Details and patient eligibility

About

This study will address this gap by providing comprehensive data on disease burden from a caregiver perspective in a Canadian population, ultimately supporting improved clinical decision-making and healthcare resource allocation.

Enrollment: 100 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

1. Aged ≥18 years;
2. Caregiver of a child aged ≥2 to ≤11 years with mild to moderate atopic dermatitis;
3. Able to read and understand French or English;
4. Willing and able to provide written informed consent.

Exclusion criteria

1. Caregivers whose child has been diagnosed with severe atopic dermatitis ;
2. Caregivers whose child is currently treated with oral or topical Janus Kinase Inhibitor);
3. Caregivers whose child is currently participating in a clinical trial for atopic dermatitis;
4. Other parent or caregiver within the household of the child with atopic dermatitis.

Trial design

100 participants in 1 patient group

Caregiver of child with atopic dermatitis

Description:

Caregiver of a child aged ≥2 to ≤11 years with mild to moderate atopic dermatitis

Treatment:

Other: No Intervention: Observational Cohort